| Capivasertib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 62show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 11 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Prostate Neoplasmcancer 5 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 4 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic and Lymphoid Cell Neoplasmcancer_family 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphoma 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Solid Neoplasm 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Solid Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Uterine Corpus Neoplasm 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melanomacancer_family 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Melanoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Endometrial Adenocarcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Endometrial Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Endometrial Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Endometrial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasmcancer_family 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 2 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 2 | Observed | clinicaltrials | graph → |